<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03730454</url>
  </required_header>
  <id_info>
    <org_study_id>17-136</org_study_id>
    <nct_id>NCT03730454</nct_id>
  </id_info>
  <brief_title>Transanastomotic Tube for Proximal Esophageal Atresia With Distal Tracheoesophageal Fistula Repair</brief_title>
  <acronym>TT TEF</acronym>
  <official_title>A Multi-Center Randomized Trial of Transanastomotic Tube for Proximal Esophageal Atresia With Distal Tracheoesophageal Fistula Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Phoenix Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Phoenix Children's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial will compare the effectiveness of two common surgical practices for Type C
      esophageal atresia repair: esophageal atresia (EA) with distal tracheoesophageal fistula
      (TEF). Infants with EA/TEF requiring surgical intervention will be recruited. Subjects will
      be randomized to either repair with or without transanstomotic tube (TT) during esophageal
      anastomosis creation. Primary outcome is symptomatic anastomotic stricture development
      requiring dilation within 12 months.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Esophageal atresia a congenital condition requiring surgical intervention. The most common
      configuration is Gross type C, proximal EA with distal TEF (EA/TEF). The operation for type C
      includes tracheoesophageal fistula closure and esophageal anastomosis creation. Although
      mortality has markedly decreased since the operation was first described, overall
      complication rate remains at 62%, with the most common complication being anastomotic
      stricture, 43%.

      During the creation of esophageal anastomosis, two common practices are to either use or not
      use a transanastomtic tube (TT) across the anastomosis. However the utility and benefits of
      TT have not been validated. A recent retrospective analysis by the Midwestern Pediatric
      Surgical Research Consortium identified anastomotic stricture to be the most common
      postoperative complications (43%). On univariate analysis, only utilization of a TT was
      significantly associated with strictures (p=0.013). On multivariate analysis after adjusting
      for both pre and perioperative variables, TT use remained significant with an odd ratio (OR)
      of 1.91 (p=0.04).

      Given the inherent limitations and biases of retrospective analysis, there is a critical need
      for a prospective multi-institutional study to validate this finding. The Western Pediatric
      Surgical Research Consortium (WPSRC) consists of 9 children's hospitals including Phoenix
      Children's Hospital, Doerbnercher Children's Hospital, Primary Children's Hospital, Lucille
      Packard Children's Hospital, Seattle Children's Hospital, Colorado Children's Hospital,
      Children's Hospital of Los Angeles, Rady Children's Hospital, and Benioff Children's
      Hospital. The WPSRC will conduct a prospective randomized control trial comparing the effects
      of TT use. Target enrollment is 150. One group of patients will receive TTs and another group
      of patients will not receive TTs. We hypothesize that the use of TT will result in increased
      anastomotic stricture formation. Primary outcome is symptomatic anastomotic stricture
      requiring dilation within 12 months.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 11, 2018</start_date>
  <completion_date type="Anticipated">May 2020</completion_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Multisite randomized control trial.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Anastomotic stricture</measure>
    <time_frame>12 months</time_frame>
    <description>Symptomatic anastomotic stricture requiring dilation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anastomotic Leak</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrent Fistula</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vocal cord injury</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unplanned return to OR</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of perenteral nutrition</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Stay</measure>
    <time_frame>12 months</time_frame>
    <description>Length of stay during hospitalization for primary repair</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Esophageal Atresia</condition>
  <condition>Tracheoesophageal Fistula</condition>
  <arm_group>
    <arm_group_label>Group A. Transanastomotic Tube</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group A. Transanastomotic Tube: Standard repair of EA/TEF will be performed. TT will be used during the esophageal anastomosis creation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B. No Transanastomotic Tube</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group B. No Transanastomotic tube group: Standard repair of EA/TEF will be performed. TT will NOT be used during the esophageal anastomosis creation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transanastomotic Tube (5FR)</intervention_name>
    <description>5FR tube left in place for 5 days after completion of esophageal anastomosis.</description>
    <arm_group_label>Group A. Transanastomotic Tube</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No Transanastomotic Tube</intervention_name>
    <description>No transanastomotic tube used during repair</description>
    <arm_group_label>Group B. No Transanastomotic Tube</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infants diagnosed with type C esophageal atresia: proximal esophageal atresia and
             distal tracheoesophageal fistula

          -  Primary repair of the esophageal atresia within the first six months of life

          -  Minimum follow up of 1 year (12 months)

        Exclusion Criteria:

          -  Other types of esophageal atresia without esophageal anastomosis creation

          -  Major anomaly that influences likelihood of developing primary outcome or affects
             surgical treatment considerations
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>6 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Justin Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Phoenix Children's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Phoenix Children's Hospital</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Justin Lee, MD</last_name>
      <phone>602-933-7007</phone>
      <email>jlee8@phoenixchildrens.com</email>
    </contact>
    <contact_backup>
      <last_name>Bethany L Sussman, PhD</last_name>
      <phone>(602) 933-0112</phone>
      <email>bsussman@phoenixchildrens.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lorraine Kelley-Quon, MD</last_name>
      <phone>323-361-1628</phone>
      <email>lkquon@chla.usc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Rita Burke</last_name>
      <email>riburke@chla.usc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Lorriane Kelley-Quon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rady Children's Hospital</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David Lazar, MD</last_name>
      <email>Dlazar@rchsd.org</email>
    </contact>
    <contact_backup>
      <last_name>Sneha Nicholson</last_name>
      <email>SNicholson@rchsd.org</email>
    </contact_backup>
    <investigator>
      <last_name>David Lazar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karen Kling, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Benioff Children's Hospital</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94158</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Benjamin Padilla, MD</last_name>
      <phone>415-476-4086</phone>
      <email>Benjamin.Padilla@ucsf.edu</email>
    </contact>
    <contact_backup>
      <last_name>Akbar Khan, MPH</last_name>
      <phone>415-476-4086</phone>
      <email>Akbar.Khan@UCSF.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Benjamin Padilla, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lucile Packard Children's Hospital</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Claudia Mueller, MD, PhD</last_name>
      <phone>650-723-6439</phone>
      <email>ClMueller@stanfordchildrens.org</email>
    </contact>
    <contact_backup>
      <last_name>Michelle Gibson, BA</last_name>
      <phone>650-723-6439</phone>
      <email>mlgibson@stanford.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Claudia Mueller, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stephen Shew, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rony Marwan, MD</last_name>
      <phone>720-777-6549</phone>
      <email>rony.marwan@childrenscolorado.org</email>
    </contact>
    <contact_backup>
      <last_name>Tyler Dobbs, MS</last_name>
      <phone>(720) 777-3190</phone>
      <email>Tyler.Dobbs@childrenscolorado.org</email>
    </contact_backup>
    <investigator>
      <last_name>Rony Marwan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Doernbecher Children's Hospital</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elizabeth Fialkowski, MD</last_name>
      <phone>503-494-7764</phone>
      <email>fialkows@ohsu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Brandy Gonzales</last_name>
      <email>gonzalbr@ohsu.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Elizabeth Fialkowski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kenneth Azarow, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Primary Children's Hospital</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84113</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Katie Russell, MD</last_name>
      <phone>801-662-2956</phone>
      <email>katie.russell@hsc.utah.edu</email>
    </contact>
    <investigator>
      <last_name>Katie Russell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seattle Children's Hospital</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Caitlin Smith, MD</last_name>
      <phone>206-987-7419</phone>
      <email>caitlin.smith@seattlechildrens.org</email>
    </contact>
    <contact_backup>
      <last_name>De'Angela Westre</last_name>
      <phone>206-987-7419</phone>
      <email>DeAngela.Westre@seattlechildrens.org</email>
    </contact_backup>
    <investigator>
      <last_name>Caitlin Smith, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>November 1, 2018</study_first_submitted>
  <study_first_submitted_qc>November 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 5, 2018</study_first_posted>
  <last_update_submitted>November 1, 2018</last_update_submitted>
  <last_update_submitted_qc>November 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Phoenix Children's Hospital</investigator_affiliation>
    <investigator_full_name>Justin Lee, MD</investigator_full_name>
    <investigator_title>Pediatric Surgeon</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esophageal Atresia</mesh_term>
    <mesh_term>Tracheoesophageal Fistula</mesh_term>
    <mesh_term>Fistula</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 7, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/54/NCT03730454/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

